Azolotriazinone melanin concentrating hormone receptor-1 antagonists

US8580959B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Pratik Devasthale · Plainsboro, US
• William N. Washburn · Titusville, US
• Kishore V. Renduchintala · Hyderabad, IN
• Radhakrishnan Sridhar · Chandapura, IN

Key dates

• Filing date: Oct 8, 2009
• Grant date: Nov 12, 2013
• Expiry date: Jul 30, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P3/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula Iwherein the variables are defined herein.